AiDEX CGMs has received approval in Brazil, officially launching into the Brazilian market!
-
Recent Developments: MicroTech Medical's AiDEX CGMS recently cleared the rigorous assessment by the Brazilian National Health Surveillance Agency (ANVISA) and has forged a strategic partnership with the esteemed local glucose equipment distributor, Medlevensohn. This milestone marks the official entry of AiDEX CGMS into the Brazilian market.
-
Significance: This initiative not only represents a significant breakthrough for MicroTech Medical in its internationalization strategy but also introduces unprecedented convenience and precision in glucose management tools for diabetic patients in Brazil.
A Robust Fusion of Technology and Market: As a leading enterprise specializing in intelligent medical device development, MicroTech Medical's core product, AiDEX Continuous Glucose Monitoring System (CGMS), employs advanced sensor technology to accurately and real-time monitor patients' glucose levels. This product has not only garnered high acclaim domestically but has also demonstrated remarkable performance internationally, showcasing strong innovative capabilities and technological advantages.
Strategic Partnership: Medlevensohn, Brazil's premier professional chronic disease diagnostic service provider and a specialized distributor in diabetes diagnostics, brings extensive experience in product distribution and medical education training. Their collaboration with MicroTech Medical forms a potent alliance of CGMS technological innovation and market expertise.
-
.webp?d=8be02a895c77b7cced)
Joint Market Strategies: MicroTech Medical and Medlevensohn have collaborated on a range of market strategies, including product demonstrations, sharing clinical application cases, and partnering with local medical institutions. These efforts aim to expedite the acceptance and recognition of AiDEX CGMS by healthcare professionals and patients, ultimately enhancing the overall standard of diabetes management in Brazil.Comprehensive Training: Under the guidance of Walter Liang, General Manager of the International Unit, MicroTech Medical's international marketing team meticulously prepared for a comprehensive training session. Key members traveled to Brazil to conduct meticulous training for Medlevensohn. The training, attended by Medlevensohn's founder, executives, and staff, deepened the partnership and bolstered confidence in AiDEX CGMS.
Future Outlook: The collaboration between MicroTech Medical and Medlevensohn not only represents a commercial triumph but also underscores a proactive push for the global medical and health industry. It is anticipated that AiDEX CGMS will see expanded application, benefiting more diabetic patients worldwide. MicroTech Medical remains committed to continuous technological innovation and market expansion, spearheading the advancement of intelligent medical devices and contributing to the global health sector.
